Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance.

• Hannah Åbacka,
• Jesper S. Hansen,
• Peng Huang,
• Raminta Venskutonytė,
• Axel Hyrenius-Wittsten,
• Giulio Poli,
• Tiziano Tuccinardi,
• Carlotta Granchi,
• Filippo Minutolo,
• Anna K. Hagström-Andersson,
• Karin Lindkvist-Petersson

Affiliations

Hannah Åbacka

Dept. of Experimental Medical Science, Medical Structural Biology, Lund University, Sweden;

Jesper S. Hansen

Dept. of Experimental Medical Science, Medical Structural Biology, Lund University, Sweden;

Peng Huang

Dept. of Experimental Medical Science, Medical Structural Biology, Lund University, Sweden;

Raminta Venskutonytė

Dept. of Experimental Medical Science, Medical Structural Biology, Lund University, Sweden;

Axel Hyrenius-Wittsten

Dept. of Laboratory Medicine, Division of Clinical Genetics, Lund University, Sweden;

Giulio Poli

Department of Pharmacy, University of Pisa, Pisa, Italy

Tiziano Tuccinardi

Department of Pharmacy, University of Pisa, Pisa, Italy

Carlotta Granchi

Department of Pharmacy, University of Pisa, Pisa, Italy

Filippo Minutolo

Department of Pharmacy, University of Pisa, Pisa, Italy

Anna K. Hagström-Andersson

Dept. of Laboratory Medicine, Division of Clinical Genetics, Lund University, Sweden;

Karin Lindkvist-Petersson

Dept. of Experimental Medical Science, Medical Structural Biology, Lund University, Sweden;